Company Profile

XenoCept Inc
Profile last edited on: 6/17/22      CAGE:       UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
----
First Award
2005
Latest Award
2005
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1615 Stonehenge Place
Little Rock, AR 72212
   N/A
   crewmarkd@uams.edu
   N/A
Location: Single
Congr. District: 02
County: Pulask

Public Profile

This Company is based on recent discoveries in xenotransplantation, the transplantation of organs from one species to another. By concentrating on abrogating cell-mediated xenograft destruction, XenoCept will offer a promising solution to the worldwide human organ shortage by overcoming the organ rejection problems through genetic engineering to eliminate targets of T cell destruction and provide inhibitors of NK cell lysis

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2005 1 NIH $142,035
Project Title: Exploiting Porcine Cytomegalovirus Stealth Mechanisms for Xenotransplantation

Key People / Management

  Mark D Crew

Company News

There are no news available.